Forsyth Douglas

Forsyth Douglas is listed in filings as Director at Inhibrx Biosciences, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including 2 public disclosures. Recent filings connect the profile to Inhibrx Biosciences, Inc. (INBX). The current snapshot covers public activity from May 29, 2025 to Jun 4, 2026. Reported amounts are shown as $193.7K to $1.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.